Terms: = Pancreatic cancer AND FGFR4, CD334, 2264, ENSG00000160867, P22455, MGC20292, TKF, JTK2 AND Treatment
5 results:
1. Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma.
Afaq F; Agarwal S; Bajpai P; Diffalha SA; Kim HG; Peter S; Khushman M; Chauhan SC; Mukherjee P; Varambally S; Manne U
Neoplasia; 2024 Jan; 47():100951. PubMed ID: 38039923
[TBL] [Abstract] [Full Text] [Related]
2. Aberrant fgfr4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice.
Yu Y; Shi X; Zheng Q; Wang X; Liu X; Tan M; Lv G; Zhang P; Martin RC; Li Y
Int J Biol Sci; 2021; 17(10):2576-2589. PubMed ID: 34326695
[No Abstract] [Full Text] [Related]
3. Influence of NOS3 rs2070744 genotypes on hepatocellular carcinoma patients treated with lenvatinib.
Azuma S; Uojima H; Chuma M; Shao X; Hidaka H; Nakazawa T; Kondo M; Numata K; Iwabuchi S; Kako M; Maeda S; Koizumi W; Atsuda K
Sci Rep; 2020 Oct; 10(1):17054. PubMed ID: 33051476
[TBL] [Abstract] [Full Text] [Related]
4. fgfr4 promotes stroma-induced epithelial-to-mesenchymal transition in colorectal cancer.
Liu R; Li J; Xie K; Zhang T; Lei Y; Chen Y; Zhang L; Huang K; Wang K; Wu H; Wu M; Nice EC; Huang C; Wei Y
Cancer Res; 2013 Oct; 73(19):5926-35. PubMed ID: 23943801
[TBL] [Abstract] [Full Text] [Related]
5. Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer.
Leung HY; Gullick WJ; Lemoine NR
Int J Cancer; 1994 Dec; 59(5):667-75. PubMed ID: 7960240
[TBL] [Abstract] [Full Text] [Related]